Will Innovation Replace Branded Generics As Dominant Strategy For Big Pharma In Emerging Markets? (Part 2 of 2)
[Editor's note: This is part two of a two-part story; part one appeared in PharmAsia News, March 4, 2011.]
[Editor's note: This is part two of a two-part story; part one appeared in PharmAsia News, March 4, 2011.]